Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

34.86
Delayed Data
As of Oct 20
 +0.47 / +1.37%
Today’s Change
15.15
Today|||52-Week Range
37.30
+109.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues177.5M196.5M196.9M200.5M
 
 
 
 
 
Cost of Goods Sold30.8M31.4M31.4M29.2M
 
 
 
 
 
Depreciation And Amortization9.2M13.0M12.9M13.3M
 
 
 
 
 
 
Operating ExpensesGross Income137.5M152.1M152.6M158.0M
 
 
 
 
 
General Expenses131.3M137.6M138.0M119.2M
 
 
 
 
 
Research And Development19.4M18.6M17.6M18.8M
 
 
 
 
 
Total Operating Expenses171.3M182.0M182.3M161.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.2M14.5M14.6M38.8M
 
 
 
 
 
Extraordinary Credit0.000.000.002.7M
 
 
Extraordinary Charge0.00-1.3M-6.9M-21.7M
 
 
 
 
Interest Expense On Debt--2.6M1.5M1.2M
 
 
 
 
Other Expenses-2.5M1.2M1.5M-100.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.0M12.1M8.0M18.8M
 
 
 
 
 
Income Taxes-5.2M-6.2M-3.8M-6.1M
 
 
 
 
 
Minority Interest0.000.000.00-200.0K
 
 
Net Income-1.2M5.9M4.2M12.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.8M68.2M68.1M68.2M
 
 
 
 
 
Shares To Calculate EPS Diluted68.8M68.3M68.3M68.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02$0.09$0.06$0.19
 
 
 
 
 
EPS Diluted-$0.02$0.09$0.06$0.19